Literature DB >> 11950832

Regulation of T cell receptor CD3zeta chain expression by L-arginine.

Paulo C Rodriguez1, Arnold H Zea, Kirk S Culotta, Jovanny Zabaleta, Juan B Ochoa, Augusto C Ochoa.   

Abstract

L-Arg plays a central role in the normal function of several organ systems including the immune system. L-Arg can be depleted by arginase I produced by macrophages and hepatocytes in several disease states such as trauma and sepsis and following liver transplantation. The decrease in L-Arg levels induces a profound decrease in T cell function through mechanisms that have remained unclear. The data presented here demonstrate that Jurkat T cells cultured in medium without L-Arg (L-Arg-free RPMI) have a rapid decrease in the expression of the T cell antigen receptor zeta chain (CD3zeta), the principal signal transduction element in this receptor, and a decrease in T cell proliferation. This phenomenon is completely reversed by the replenishment of L-Arg but not other amino acids. These changes are not caused by cell apoptosis; instead, the diminished expression of CD3zeta protein is paralleled by a decrease in CD3zeta mRNA. This change in CD3zeta mRNA expression is not caused by a decrease in the transcription rate but rather by a significantly shorter CD3zeta mRNA half-life. This mechanism is sensitive to cycloheximide. Therefore, the regulation of L-Arg concentration in the microenvironment could represent an important mechanism to modulate the expression of CD3zeta and the T cell receptor and consequently of T cell function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11950832     DOI: 10.1074/jbc.M110675200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  163 in total

Review 1.  Arginine: an unusual dietary requirement of pre-B lymphocytes?

Authors:  Tucker W LeBien
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

Review 2.  A guide to immunometabolism for immunologists.

Authors:  Luke A J O'Neill; Rigel J Kishton; Jeff Rathmell
Journal:  Nat Rev Immunol       Date:  2016-07-11       Impact factor: 53.106

Review 3.  Regulation of suppressive function of myeloid-derived suppressor cells by CD4+ T cells.

Authors:  Srinivas Nagaraj; Dmitry I Gabrilovich
Journal:  Semin Cancer Biol       Date:  2012-01-31       Impact factor: 15.707

4.  Combination therapy with L-arginine and α-PD-L1 antibody boosts immune response against osteosarcoma in immunocompetent mice.

Authors:  Xiaojun He; Haiqing Lin; Li Yuan; Binghao Li
Journal:  Cancer Biol Ther       Date:  2017-01-03       Impact factor: 4.742

5.  Discovery and Pharmacokinetics of Sulfamides and Guanidines as Potent Human Arginase 1 Inhibitors.

Authors:  Roman Blaszczyk; Joanna Brzezinska; Barbara Dymek; Paulina S Stanczak; Marcin Mazurkiewicz; Jacek Olczak; Julita Nowicka; Karolina Dzwonek; Agnieszka Zagozdzon; Jakub Golab; Adam Golebiowski
Journal:  ACS Med Chem Lett       Date:  2020-03-13       Impact factor: 4.345

6.  Embryonic stem cell-derived haematopoietic progenitor cells down-regulate the CD3 ξ chain on T cells, abrogating alloreactive T cells.

Authors:  Eun-Mi Kim; Bob Miyake; Manish Aggarwal; Ruth Voetlause; Maia Griffith; Nicholas Zavazava
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

7.  Adoptive T-Cell Therapy for Solid Tumors.

Authors:  Oladapo Yeku; Xinghuo Li; Renier J Brentjens
Journal:  Am Soc Clin Oncol Educ Book       Date:  2017

8.  Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism.

Authors:  Lyse A Norian; Paulo C Rodriguez; Leigh A O'Mara; Jovanny Zabaleta; Augusto C Ochoa; Marina Cella; Paul M Allen
Journal:  Cancer Res       Date:  2009-03-17       Impact factor: 12.701

9.  Development and evaluation of a host-targeted antiviral that abrogates herpes simplex virus replication through modulation of arginine-associated metabolic pathways.

Authors:  Maria Dulfary Sanchez; Augusto C Ochoa; Timothy P Foster
Journal:  Antiviral Res       Date:  2016-05-15       Impact factor: 5.970

10.  Tumor microenvironment and myeloid-derived suppressor cells.

Authors:  Viktor Umansky; Alexandra Sevko
Journal:  Cancer Microenviron       Date:  2012-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.